CytoCares Inc
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of CC312 for Relapsed/Refractory Autoimmune Diseases (NCT07193810) | CytoCares Inc | 2025-09-23 |
| Safety and Efficacy Study of CC312 for Moderate to Severe SLE (NCT07177911) | CytoCares Inc | 2025-09-11 |
| Safety Study of CC312 in Autoimmune Disease Patients (NCT06888960) | CytoCares Inc | 2024-11-08 |
| Safety Study of CC312 in Adult Patients With Relapsed/Refractory CD19 Positive B-cell Hematologic Malignancies (NCT06037018) | CytoCares Inc | 2023-08-07 |
Track CytoCares Inc automatically
Every clearance here is in the API, with alerts when new ones post.